CONFERENCE ON MODERN TENDENCIES IN TREATMENT OF HEPATITIS C IN MONGOLIA AND INTERNATIONALLY WAS HELD
International Conference on “MODERN TENDENCIES IN TREATMENT OF HEPATITIS C IN MONGOLIA AND INTERNATIONALLY” was held today at Blue Sky Hotel Conference Hall. This conference was organized by “Asia-Pharma” Co., Ltd in cooperation with “China Sinopharm International Corporation” group of China and “Hetero Drugs Limited” of India. Also officials from the Ministry of Health, National Center for Contagious Diseases and representatives from the Mongolian Institute of Gastroenterology participated in the conference.
Hepatitis C is a major cause of liver cirrhosis and liver cancer, and in 2012 Mongolia's mortality rate was 9 times higher than the global average. Thus the Mongolian government and the Ministry of Health is paying particular attention to the problem of prevention, detection and treatment of Hepatitis C. With this problem in mind “Wholesome Mongolia" national program was developed in 2015 and is implementing a multidisciplinary approach. As part of the national program and its social responsibility, "Asia-Pharma" Co., Ltd is importing Ledifos, highly effective in treatment of Hepatitis C and officially patented by US company Gilead Sciences, in cooperation with the “China Sinopharm International Corporation” group and ”Hetero Drugs Limited” of India, to provide affordable and cost-effective medical services for consumers with low and average income.